| Product Code: ETC13267923 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Lab Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Lab Diagnostics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Lab Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Lab Diagnostics Market - Industry Life Cycle |
3.4 North America Lab Diagnostics Market - Porter's Five Forces |
3.5 North America Lab Diagnostics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Lab Diagnostics Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Lab Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 North America Lab Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.9 North America Lab Diagnostics Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 North America Lab Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 North America Lab Diagnostics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Lab Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Lab Diagnostics Market Trends |
6 North America Lab Diagnostics Market, 2021 - 2031 |
6.1 North America Lab Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Lab Diagnostics Market, Revenues & Volume, By Clinical Chemistry and Immunoassays, 2021 - 2031 |
6.1.3 North America Lab Diagnostics Market, Revenues & Volume, By Infectious Disease Testing, 2021 - 2031 |
6.1.4 North America Lab Diagnostics Market, Revenues & Volume, By Microbiology, 2021 - 2031 |
6.1.5 North America Lab Diagnostics Market, Revenues & Volume, By Mycology and Parasitology, 2021 - 2031 |
6.1.6 North America Lab Diagnostics Market, Revenues & Volume, By Haematology, 2021 - 2031 |
6.1.7 North America Lab Diagnostics Market, Revenues & Volume, By POCT, 2021 - 2031 |
6.1.8 North America Lab Diagnostics Market, Revenues & Volume, By Human Chorionic Gonadotropin (HCG), 2021 - 2031 |
6.1.9 North America Lab Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Lab Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Lab Diagnostics Market, Revenues & Volume, By Reagents & Consumables, 2021 - 2031 |
6.2.3 North America Lab Diagnostics Market, Revenues & Volume, By Analysers & Instruments, 2021 - 2031 |
6.2.4 North America Lab Diagnostics Market, Revenues & Volume, By Accessories, 2021 - 2031 |
6.3 North America Lab Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Lab Diagnostics Market, Revenues & Volume, By Blood, 2021 - 2031 |
6.3.3 North America Lab Diagnostics Market, Revenues & Volume, By Urine, 2021 - 2031 |
6.3.4 North America Lab Diagnostics Market, Revenues & Volume, By Sputum, 2021 - 2031 |
6.3.5 North America Lab Diagnostics Market, Revenues & Volume, By Tissue, 2021 - 2031 |
6.3.6 North America Lab Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Lab Diagnostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Lab Diagnostics Market, Revenues & Volume, By Metabolic Disorders, 2021 - 2031 |
6.4.3 North America Lab Diagnostics Market, Revenues & Volume, By Infections, 2021 - 2031 |
6.4.4 North America Lab Diagnostics Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.4.5 North America Lab Diagnostics Market, Revenues & Volume, By Genetic Disorders, 2021 - 2031 |
6.4.6 North America Lab Diagnostics Market, Revenues & Volume, By Urology, 2021 - 2031 |
6.4.7 North America Lab Diagnostics Market, Revenues & Volume, By Gynaecology, 2021 - 2031 |
6.4.8 North America Lab Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 North America Lab Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Lab Diagnostics Market, Revenues & Volume, By Hospital-Based Labs, 2021 - 2031 |
6.5.3 North America Lab Diagnostics Market, Revenues & Volume, By Stand-Alone Labs, 2021 - 2031 |
6.5.4 North America Lab Diagnostics Market, Revenues & Volume, By Diagnostic Chains, 2021 - 2031 |
6.5.5 North America Lab Diagnostics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Lab Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Lab Diagnostics Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.6.3 North America Lab Diagnostics Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.6.4 North America Lab Diagnostics Market, Revenues & Volume, By Other, 2021 - 2031 |
7 North America Lab Diagnostics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Lab Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Lab Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Lab Diagnostics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
7.3.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.2 Canada Lab Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Lab Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.4.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.4.2 Canada Lab Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.4.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By Sample Type, 2021 - 2031 |
7.5 North America Lab Diagnostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.5.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.5.2 Canada Lab Diagnostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.5.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By Therapeutic Area, 2021 - 2031 |
7.6 North America Lab Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.2 Canada Lab Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Lab Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.1 United States (US) Lab Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.2 Canada Lab Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.7.3 Rest of North America Lab Diagnostics Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Lab Diagnostics Market Key Performance Indicators |
9 North America Lab Diagnostics Market - Export/Import By Countries Assessment |
10 North America Lab Diagnostics Market - Opportunity Assessment |
10.1 North America Lab Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Lab Diagnostics Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Lab Diagnostics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.4 North America Lab Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10.5 North America Lab Diagnostics Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
10.6 North America Lab Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
10.7 North America Lab Diagnostics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Lab Diagnostics Market - Competitive Landscape |
11.1 North America Lab Diagnostics Market Revenue Share, By Companies, 2022 |
11.2 North America Lab Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here